Skip to main content

Bioanalysis Zone is part of Taylor & Francis Group.

  • Taylor & Francis
  • About us
  • Our journals
  • Our Digital Hubs

Taylor & Francis Group is a trading division of Informa that operates through various Informa legal entities including, but not limited to, Informa UK Limited, with the registered address at 5 Howick Place, London, SW1P 1WG, UK.

Taylor & Francis
logo
 
  • Home
  • Awards
  • Events
  • Features
    • An author's perspective
    • Ask the Experts
    • Conference reports
    • eBooks
    • Expert opinion
    • In the Zone
    • Journal articles
    • Journal content
    • Spotlights
    • Tech Digest

    Follow us on social media

  • Glossary
  • Topics
    • Applications
      • Advanced therapies
      • Biomarkers
      • Clinical
      • Diagnostics
      • Drug development
      • Forensics
      • Patient-centric sampling
      • Sports drug testing
      • Toxicology
      • Vaccines
    • Industry updates & regulations
      • Biopharmaceuticals
      • Collaborations & mergers
      • Data processing and interpretation
      • Regulated bioanalysis
    • Molecules
      • Antibodies | ADCs
      • Biosimilars
      • Large molecules
      • Metabolites
      • Oligonucleotides
      • Small molecules
    • Techniques
      • Automation
      • Chromatography
      • Imaging
      • LBA
      • Microsampling
      • MS (LC–MS/MS, HRMS, IMS)
      • Sample preparation

    Follow us on social media

  • Multimedia
    • Coffee chats
    • Infographics
    • Interviews
    • Panel discussions
    • Podcasts
    • Videos
    • Webinars

    Follow us on social media

  • News
  • Partners
  • Register
WEBINAR: Optimizing method development for efficiency, throughput and data quality 1 days 17 hours 11 mins 33 secs REGISTER NOW

Presentation: Metabolomics for discovering the functions of genes with embryonic-lethal mutations (Agilent)

7 Oct 2014
General interest

Presentation held by Steven S. Gross, Department of Pharmacology Weill Cornell Medical College (NY, NY).

sgross

 

Click here to view presentation.

Related Links

  • Agilent Technologies

 

Top content

  • Webinar Q&A follow-up: A masterclass in advanced analytical assays for bioanalysis of oligonucleotides
  • New AI tool predicts multiple sclerosis drug response
  • Waters upgrade Xevo MRT performance: who doesn’t want sharper, faster imaging?

Related tags

metabolomics
Previous article

Related articles

6 JUL 2020 GENERAL INTEREST
The latest metabolomics developments: an interview with Martin Giera
21 NOV 2011 CLINICAL
Artificial microorgans: a microfluidic tool for in vitro assessment of toxicity
4 NOV 2014 CHROMATOGRAPHY
Interview with Adam Rosebrock (University of Toronto) on his metabolomics research
28 MAR 2017 ASK THE EXPERTS
Ask the Experts: Ian Wilson
17 FEB 2016 DRUG DEVELOPMENT
Survey on the tiered approach for Japanese bioanalysts operated by Japan bioanalysis forum DG2014-09
25 JUL 2017 NEWS
Thermo Fisher Scientific and SRI International Collaborate to Enhance Small Molecule Research
  • About
  • Advertising & Sponsorship
  • Learn
    • Awareness
    • Education zone
    • Professional development
  • Contact Us
  • Permissions
  • Products
  • Zone Leaders
  • Whitelist Emails
  • Accessibility

Contact

Contact Us

Office info

Bioanalysis Zone is powered by Taylor & Francis Group

Bioanalysis Zone, 2-4 Park Square, Milton Park, Abingdon, Oxfordshire, OX14 4RN, United Kingdom
  • Taylor & Francis Group
  • Cookie Policy
  • Privacy Policy
  • Terms & Conditions
  • © 2025 Bioanalysis Zone